Neil Gallagher
President at SYNDAX PHARMACEUTICALS, INC.
Net worth: 1 M $ as of 30/03/2024
Profile
Neil Gallagher is currently the Director at Zymeworks, Inc. since 2024 and the President, Head-Research & Development at Syndax Pharmaceuticals, Inc. since 2023.
Previously, he worked at AbbVie, Inc. as the Chief Medical Officer & Head-Development.
Dr. Gallagher holds a doctorate degree from the University of Birmingham and an undergraduate degree from Trinity College, Cambridge.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 07/03/2024 | 47,813 ( 0.06% ) | 1 M $ | 30/03/2024 |
Neil Gallagher active positions
| Companies | Position | Start |
|---|---|---|
| SYNDAX PHARMACEUTICALS, INC. | President | 09/04/2023 |
| ZYMEWORKS INC. | Director/Board Member | 01/04/2024 |
Former positions of Neil Gallagher
| Companies | Position | End |
|---|---|---|
| ABBVIE INC. | President | - |
Training of Neil Gallagher
| University of Birmingham | Doctorate Degree |
| Trinity College, Cambridge | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Health Technology |
| ABBVIE INC. | Health Technology |
| ZYMEWORKS INC. | Health Technology |
- Stock Market
- Insiders
- Neil Gallagher
